RhumbLine Advisers
INBX icon

RhumbLine Advisers’s Inhibrx INBX Stock Holding History

RhumbLine Advisers’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.14M Buy
12,056
+623
+5% +$62.4K ﹤0.01% 2233
2026
Q1 		$769K Sell
11,433
-2
-0% -$148 ﹤0.01% 2343
2025
Q4 		$903K Sell
11,435
-2,300
-17% -$157K ﹤0.01% 2292
2025
Q3 		$463K Sell
13,735
-599
-4% -$14.7K ﹤0.01% 2750
2025
Q2 		$205K Sell
14,334
-1,098
-7% -$14.2K ﹤0.01% 3219
2025
Q1 		$216K Buy
15,432
+625
+4% +$8.49K ﹤0.01% 3071
2024
Q4 		$228K Buy
14,807
+997
+7% +$15.2K ﹤0.01% 3124
2024
Q3 		$216K Sell
13,810
-349
-2% -$4.9K ﹤0.01% 3198
2024
Q2 		$201K Buy
+14,159
New +$221K ﹤0.01% 3225

Other funds holding INBX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

RhumbLine Advisers's INBX Position: Q2 2026 in Review

RhumbLine Advisers increased its Inhibrx (INBX) stake by 5.4% in Q2 2026, buying an estimated $62.4K and bringing the position to 12,056 shares worth $1.14M. The position accounts for ﹤0.01% of the portfolio, ranked #2233.

RhumbLine Advisers first reported a position in INBX in Q2 2024 and has held it in 9 quarters since. 163 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • RhumbLine Advisers held 12,056 shares of Inhibrx worth $1.14M as of Q2 2026.
  • RhumbLine Advisers bought 623 Inhibrx shares in Q2 2026, an estimated $62.4K.
  • Inhibrx made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #2233 holding.
  • RhumbLine Advisers first reported a position in Inhibrx in Q2 2024 and has held it in 9 quarters since.
  • 163 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.